Corona in general

In a study recently published on the bioRxiv* preprint server, researchers investigated the difference in replication efficiency or IFN sensitivity of the four VOCs. // 22.11.2021

In a study recently published on the bioRxiv* preprint server, researchers investigated the IFITM2 dependency of SARS-CoV-2 VOCs, including the delta variant for efficient infection. // 22.11.2021

In a recent study, researchers explored the effects of RV, HDM, and SARS-CoV-2 on differentiated primary human bronchial epithelial cells (HBECs) in vitro and in experimental in vivo RV infection in healthy subjects and asthmatic patients. // 22.11.2021

In a new study published in the journal Human Immunology, scientists sought to better understand how B-cell immune repertoire changes over time during SARS-CoV-2 infection by comprehensively characterizing the dynamics of immunoglobin heavy chain (IGH) repertoire in COVID-19 patients. // 22.11.2021

Now, a new study published in the journal IEEE Access seeks to better understand the dynamics of the spread of COVID-19 and evaluates the evidence of its chaotic behavior in the US and globally using a compartmental model. // 22.11.2021

A new review article determines the role of UV disinfection for nosocomial transmission of COVID-19 and other infectious diseases. // 22.11.2021

Researchers from the Centers for Disease Control have investigated a case in Massachusetts that showed a high proportion of vaccine breakthrough infections. // 22.11.2021

Researchers recently used bioinformatics analysis techniques to explore the diseases caused by SARS-CoV-2 infection in the human digestive tract. // 22.11.2021

Elucidating the origin of the pandemic requires understanding of the Wuhan outbreak // 18.11.2021

The COVID-19 pandemic has irreversibly altered our lives in many ways. However, available COVID vaccines are effective against (symptomatic) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, hospitalizations, and even death. // 19.11.2021

In the sixth-most populated state of India – Tamil Nadu, three rounds of a district-level serological study were conducted through two COVID waves. // 18.11.2021

A new study published in the open-access journal Cells aimed to clarify the role of NK and T cell subsets in SARS-CoV-2 infection in hospitalized COVID-19 patients to unravel their potential association with disease severity. // 18.11.2021

A study recently published on the medRxiv* preprint server observed the presence of SARS-CoV-2 RNA in five schools (96 classrooms) in Davis, California (USA), by collecting weekly surface-swab samples from classroom floors and/or portable high-efficiency particulate air (HEPA) units. // 18.19.2021

Immunity acquired after recovering from SARS-CoV-2 infection is not sufficient in protecting against reinfection from variants. // 18.11.2021

The findings reveal that inhaled prostacyclin significantly improves oxygenation in ARDS patients who had COVID-19. // 17.11.2021

A study characterized the total virome of game animals from five mammalian orders using the total RNA sequencing technique. // 17.11.2021

Researchers examined the efficacy of UVC light prototype devices to understand the duration and wavelength of UVC radiation needed for SARS-CoV-2 inactivation. // 17.11.2021

Researchers from the University of Wurzburg in Germany have been attempting to create a new method for determining the R0 using excess mortality data. // 18.11.2021

Researchers examine the impact of demographic factors and antibody responses following SARS-CoV-2 reinfection. // 17.11.2021

Canadian public health researchers recently published a study in the journal Antiviral Research wherein they described generating a panel of murine hybridomas recognizing SARS-CoV-2 spike protein or nucleoprotein, capable of neutralizing the SARS-CoV-2 variants of concern, proving their therapeutic potential. // 17.11.2021

A new study describes the cases and outbreaks of COVID-19 in schools and preschools in Norway to evaluate the strategy of keeping them open with control measures in place. // 18.11.2021

AstraZeneca's antibody treatment has been shown to be highly effective at preventing Covid in people who may not respond well to vaccines. // 18.11.2021

A new study has been published that evaluates the benefits of VMVP by estimating the benefits of vaccination and exclusion of unvaccinated people from different settings. // 16.11.2021

When a team of doctors, scientists and engineers at Addenbrooke's Hospital and the University of Cambridge placed an air filtration machine in COVID-19 wards, they found that it removed almost all traces of airborne SARS-CoV-2. // 17.11.2021

In a paradigm-shifting paper currently available on the bioRxiv* preprint server, the researchers have dramatically extended the possibilities of computational microscopy in order to better understand both structure and dynamics of respiratory aerosols laden with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). // 16.11.2021

A new study investigates serum from COVID-19 convalescents and uninfected individuals to determine the molecular mechanisms of host responses. // 15.11.2021

A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated; however, it did not substantially reduce incidents of hospitalizations and/or deaths among people with COVID-19, according to a late-breaking clinical trial presented today at the American Heart Association's Scientific Sessions 2021. // 15.11.2021

Researchers conducted a comprehensive, longitudinal, long-term immune study, including functional assays to assess immune fitness against antigenically different VoC. The study is currently available on the preprint server medRxiv* while awaiting peer review. // 15.11.2021

A new study concludes that a COVID-19 mRNA vaccine is around five times more effective at preventing hospitalization than a previous SARS-CoV-2 infection. 5.11.2021

We estimate the potential remaining COVID-19 burden in 19 European countries by estimating the proportion of each country’s population that has acquired immunity to severe disease through infection or vaccination. // 10.11.2021